UnknownNot Applicable

Endotherapy for Painless Chronic Pancreatitis

China60 participantsStarted 2022-03

Plain-language summary

This is a prospective randomized controlled trial. . Patients will be divided into conservative or endoscopic group and fecal pancreatic elastase-1 (FE-1) is tested to evaluate pancreatic exocrine function. The effect of extracorporeal shock wave lithotripsy and endoscopic treatment on the progression of chronic pancreatitis in painless patients will be determined.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosed with chronic pancreatitis without pain attack related with chronic pancreatitis; * calcified stone in the cephalic or corporeal portion of the main pancreatic duct with upstream duct dilation; * no ERCP or ESWL carried out before admission; Exclusion Criteria: * suspected to have malignant tumors; * history of pancreatic surgery or gastrojejunostomy (Billroth II); * with end-stage disease; * pregnancy or lactation; * refuse to write informed consent

What they're measuring

exocrine function of the pancreas assessed by the value of fecal elastase in μg/g

Timeframe: 12 months

Trial details

NCT IDNCT05261997

SponsorChanghai Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11

Contact for this trial

Zhuan Liao

13061921980 liaozhuan@smmu.edu.cn

View on ClinicalTrials.gov More Pancreatitis, Chronic trials